Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.
For the acute treatment of migraine attacks with or without aura in adults.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.